Reuters
26 Jun 2026, 11:49 UTC · 3h ago
Unilever explores bid for supplements maker Thorne, FT reports
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
26 Jun 2026, 11:49 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Unilever is exploring a potential acquisition of U.S. supplements maker Thorne. — A multi-billion dollar acquisition signals strategic expansion into the high-growth wellness sector, though it involves significant capital outlay.
+0.40Thorne is valued at up to $4 billion. — Establishes the scale of the potential transaction and sets a pricing benchmark for the target company's valuation.
+0.20Which stocks this story touches
Unilever is exploring a strategic acquisition to expand its supplements portfolio.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
1d ago
